Bachem Holding AG
SIX:BANB

Watchlist Manager
Bachem Holding AG Logo
Bachem Holding AG
SIX:BANB
Watchlist
Price: 67.5 CHF -3.3% Market Closed
Market Cap: 5.1B CHF
Have any thoughts about
Bachem Holding AG?
Write Note

Bachem Holding AG
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bachem Holding AG
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Bachem Holding AG
SIX:BANB
Common Shares Outstanding
CHf75m
CAGR 3-Years
21%
CAGR 5-Years
12%
CAGR 10-Years
6%
Siegfried Holding AG
SIX:SFZN
Common Shares Outstanding
CHf4.3m
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Common Shares Outstanding
CHf72.1m
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Tecan Group AG
SIX:TECN
Common Shares Outstanding
CHf12.8m
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
N/A
PolyPeptide Group AG
SIX:PPGN
Common Shares Outstanding
€33m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Common Shares Outstanding
CHf22.5m
CAGR 3-Years
29%
CAGR 5-Years
17%
CAGR 10-Years
N/A
No Stocks Found

Bachem Holding AG
Glance View

Market Cap
5.1B CHF
Industry
Life Sciences Tools & Services

Bachem Holding AG engages in the provision of peptides and oligonucleotides. The company is headquartered in Bubendorf, Basel-Landschaft and currently employs 1,639 full-time employees. The company went IPO on 2001-06-29. The firm focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The firm markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.

BANB Intrinsic Value
90.95 CHF
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Bachem Holding AG's Common Shares Outstanding?
Common Shares Outstanding
75m CHF

Based on the financial report for Jun 30, 2024, Bachem Holding AG's Common Shares Outstanding amounts to 75m CHF.

What is Bachem Holding AG's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
6%

Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for Bachem Holding AG have been 21% over the past three years , 12% over the past five years , and 6% over the past ten years .

Back to Top